Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirsi Talala

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Cancer Causes & Control : CCC|December 8, 2023
Screening history and risk of death from prostate cancer: a nested case-control study within the screening arm of the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC)Kirsi Talala, Stephen Walter, Kimmo Taari, et al.
Clinical Epidemiology|November 8, 2019
Charlson Comorbidity Index Based On Hospital Episode Statistics Performs Adequately In Predicting Mortality, But Its Discriminative Ability Diminishes Over TimeJuho Pylväläinen, Kirsi Talala, Teemu Murtola, et al.
The Prostate|May 9, 2017
The effect of non-steroidal anti-inflammatory drugs on risk of benign prostatic hyperplasiaLotta H Nygård, Kirsi Talala, Kimmo Taari, et al.
Scandinavian Journal of Urology|January 14, 2017
Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate CancerAntti Haring, Teemu J Murtola, Kirsi Talala, et al.
Scandinavian Journal of Urology|January 31, 2019
Antihypertensive drugs and prostate cancer risk in a Finnish population-based cohortAino Siltari, Teemu J Murtola, Kirsi Talala, et al.
Plos One|June 30, 2020
Antihypertensive drug use and prostate cancer-specific mortality in Finnish menAino Siltari, Teemu J Murtola, Kirsi Talala, et al.
European Urology|May 24, 2016
Number of Screening Rounds and Postscreening Prostate Cancer Incidence: Results from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer StudyTomi Pakarainen, Jani Raitanen, Kirsi Talala, et al.
British Journal of Cancer|October 19, 2016
Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate CancerKalle J Kaapu, Teemu J Murtola, Kirsi Talala, et al.
Cancers|June 24, 2022
Inverse Association between Statin Use and Cancer Mortality Relates to Cholesterol LevelAntti I Peltomaa, Kirsi Talala, Kimmo Taari, et al.
European Journal of Public Health|June 16, 2007
Health behaviours as explanations for educational level differences in cardiovascular and all-cause mortality: a follow-up of 60 000 men and women over 23 yearsMikko Laaksonen, Kirsi Talala, Tuija Martelin, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Cancer Causes & Control : CCC|December 8, 2023
Screening history and risk of death from prostate cancer: a nested case-control study within the screening arm of the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC)Kirsi Talala, Stephen Walter, Kimmo Taari, et al.
Clinical Epidemiology|November 8, 2019
Charlson Comorbidity Index Based On Hospital Episode Statistics Performs Adequately In Predicting Mortality, But Its Discriminative Ability Diminishes Over TimeJuho Pylväläinen, Kirsi Talala, Teemu Murtola, et al.
The Prostate|May 9, 2017
The effect of non-steroidal anti-inflammatory drugs on risk of benign prostatic hyperplasiaLotta H Nygård, Kirsi Talala, Kimmo Taari, et al.
Scandinavian Journal of Urology|January 14, 2017
Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate CancerAntti Haring, Teemu J Murtola, Kirsi Talala, et al.
Scandinavian Journal of Urology|January 31, 2019
Antihypertensive drugs and prostate cancer risk in a Finnish population-based cohortAino Siltari, Teemu J Murtola, Kirsi Talala, et al.
Plos One|June 30, 2020
Antihypertensive drug use and prostate cancer-specific mortality in Finnish menAino Siltari, Teemu J Murtola, Kirsi Talala, et al.
European Urology|May 24, 2016
Number of Screening Rounds and Postscreening Prostate Cancer Incidence: Results from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer StudyTomi Pakarainen, Jani Raitanen, Kirsi Talala, et al.
British Journal of Cancer|October 19, 2016
Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate CancerKalle J Kaapu, Teemu J Murtola, Kirsi Talala, et al.
Cancers|June 24, 2022
Inverse Association between Statin Use and Cancer Mortality Relates to Cholesterol LevelAntti I Peltomaa, Kirsi Talala, Kimmo Taari, et al.
European Journal of Public Health|June 16, 2007
Health behaviours as explanations for educational level differences in cardiovascular and all-cause mortality: a follow-up of 60 000 men and women over 23 yearsMikko Laaksonen, Kirsi Talala, Tuija Martelin, et al.
Pageof 7